Given the critical role of NUPR1 in breast cancer, we next developed a high-throughput screening platform for sdAbs targeting NUPR1, aiming to provide a new therapeutic approach for TNBC (Fig. 1D). This evidence concerns the gene NUPR1 and breast carcinoma.